82 FR 43572 - Importer of Controlled Substances Application: Sharp Clinical Services, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 82, Issue 179 (September 18, 2017)
Drug Enforcement Administration
Federal Register Volume 82, Issue 179 (September 18, 2017)
| Page Range | 43572-43572 | |
| FR Document | 2017-19836 |
[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)] [Notices] [Page 43572] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-19836] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Sharp Clinical Services, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 18, 2017. Such persons may also file a written request for a hearing on the application on or before October 18, 2017. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on August 23, 2017, Sharp Clinical Services, Inc., 300 Kimberton Road, Phoenixville, Pennsylvania 19460 applied to be registered as an importer of the following basic classes of controlled substances: ------------------------------------------------------------------------ Drug Controlled substance code Schedule ------------------------------------------------------------------------ Marihuana............................... 7360 I 3,4-Methylenedioxymetham-phetamine...... 7405 I Psilocybin.............................. 7437 I ------------------------------------------------------------------------ The company plans to import the listed controlled substances for analytical research, testing, and clinical trials. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale. Dated: September 11, 2017. Demetra Ashley, Acting Assistant Administrator. [FR Doc. 2017-19836 Filed 9-15-17; 8:45 am] BILLING CODE 4410-09-P
![43572 Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices
for a hearing on the application DEPARTMENT OF JUSTICE Controlled substance Drug Schedule
pursuant to 21 CFR 1301.43 on or before code
October 18, 2017. Drug Enforcement Administration Marihuana ................................ 7360 I
3,4-Methylenedioxymetham- 7405 I
ADDRESSES: Written comments should phetamine.
[Docket No. DEA–392]
be sent to: Drug Enforcement Psilocybin ................................. 7437 I
Administration, Attention: DEA Federal Importer of Controlled Substances
Register Representative/DRW, 8701 Application: Sharp Clinical Services, The company plans to import the
Morrissette Drive, Springfield, Virginia Inc. listed controlled substances for
22152. All requests for hearing must be analytical research, testing, and clinical
sent to: Drug Enforcement ACTION: Notice of application. trials. No other activity for these drug
Administration, Attn: Administrator, codes is authorized for this registration.
8701 Morrissette Drive, Springfield, Approval of permit applications will
DATES: Registered bulk manufacturers of
Virginia 22152. All requests for hearing occur only when the registrant’s
the affected basic classes, and
should also be sent to: (1) Drug business activity is consistent with what
applicants therefore, may file written
Enforcement Administration, Attn: is authorized under 21 U.S.C. 952(a)(2).
comments on or objections to the
Hearing Clerk/LJ, 8701 Morrissette Authorization will not extend to the
issuance of the proposed registration on
import of FDA approved or non-
Drive, Springfield, Virginia 22152; and or before October 18, 2017. Such
approved finished dosage forms for
(2) Drug Enforcement Administration, persons may also file a written request
commercial sale.
Attn: DEA Federal Register for a hearing on the application on or
Representative/DRW, 8701 Morrissette before October 18, 2017. Dated: September 11, 2017.
Drive, Springfield, Virginia 22152. Demetra Ashley,
ADDRESSES: Written comments should
be sent to: Drug Enforcement Acting Assistant Administrator.
SUPPLEMENTARY INFORMATION: The
Administration, Attention: DEA Federal [FR Doc. 2017–19836 Filed 9–15–17; 8:45 am]
Attorney General has delegated his
authority under the Controlled Register Representative/DRW, 8701 BILLING CODE 4410–09–P
Substances Act to the Administrator of Morrissette Drive, Springfield, Virginia
the Drug Enforcement Administration 22152. All requests for hearing must be
sent to: Drug Enforcement DEPARTMENT OF JUSTICE
(DEA), 28 CFR 0.100(b). Authority to
Administration, Attn: Administrator, Drug Enforcement Administration
exercise all necessary functions with
8701 Morrissette Drive, Springfield,
respect to the promulgation and
Virginia 22152. All requests for hearing
implementation of 21 CFR part 1301, should also be sent to: (1) Drug [Docket No. DEA–392]
incident to the registration of Enforcement Administration, Attn:
manufacturers, distributors, dispensers, Importer of Controlled Substances
Hearing Clerk/LJ, 8701 Morrissette
importers, and exporters of controlled Application: Mylan Pharmaceuticals,
Drive, Springfield, Virginia 22152; and
substances (other than final orders in Inc.
(2) Drug Enforcement Administration,
connection with suspension, denial, or Attn: DEA Federal Register ACTION: Notice of application.
revocation of registration) has been Representative/DRW, 8701 Morrissette
redelegated to the Assistant Drive, Springfield, Virginia 22152. DATES: Registered bulk manufacturers of
Administrator of the DEA Diversion
SUPPLEMENTARY INFORMATION: The the affected basic classes, and
Control Division (‘‘Assistant applicants therefore, may file written
Attorney General has delegated his
Administrator’’) pursuant to section 7 of comments on or objections to the
authority under the Controlled
28 CFR part 0, appendix to subpart R. Substances Act to the Administrator of issuance of the proposed registration in
In accordance with 21 CFR the Drug Enforcement Administration accordance with 21 CFR 1301.34(a) on
1301.34(a), this is notice that on April (DEA), 28 CFR 0.100(b). Authority to or before October 18, 2017. Such
19, 2017, Unither Manufacturing LLC, exercise all necessary functions with persons may also file a written request
331 Clay Road, Rochester, New York respect to the promulgation and for a hearing on the application
14623 applied to be registered as an implementation of 21 CFR part 1301, pursuant to 21 CFR 1301.43 on or before
importer of methylphenidate (1724), a incident to the registration of October 18, 2017.
basic class of controlled substance listed manufacturers, distributors, dispensers, ADDRESSES: Written comments should
in schedule II. importers, and exporters of controlled be sent to: Drug Enforcement
substances (other than final orders in Administration, Attention: DEA Federal
The company plans to import the
connection with suspension, denial, or Register Representative/DRW, 8701
listed substance solely for updated revocation of registration) has been
analytical testing purposes for EU Morrissette Drive, Springfield, Virginia
redelegated to the Assistant 22152. All requests for hearing must be
customer requirements. This analysis is Administrator of the DEA Diversion sent to: Drug Enforcement
required to allow the company to export Control Division (‘‘Assistant Administration, Attn: Administrator,
domestically-manufactured FDF to Administrator’’) pursuant to section 7 of 8701 Morrissette Drive, Springfield,
foreign markets. 28 CFR part 0, appendix to subpart R. Virginia 22152. All request for hearing
Dated: September 11, 2017. In accordance with 21 CFR should also be sent to: (1) Drug
sradovich on DSKBBY8HB2PROD with NOTICES
Demetra Ashley, 1301.34(a), this is notice that on August Enforcement Administration, Attn:
Acting Assistant Administrator. 23, 2017, Sharp Clinical Services, Inc., Hearing Clerk/LJ, 8701 Morrissette
[FR Doc. 2017–19830 Filed 9–15–17; 8:45 am]
300 Kimberton Road, Phoenixville, Drive, Springfield, Virginia 22152; and
Pennsylvania 19460 applied to be (2) Drug Enforcement Administration,
BILLING CODE 4410–09–P
registered as an importer of the Attn: DEA Federal Register
following basic classes of controlled Representative/DRW, 8701 Morrissette
substances: Drive, Springfield, Virginia 22152.
VerDate Sep<11>2014 19:23 Sep 15, 2017 Jkt 241001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\18SEN1.SGM 18SEN1](https://thefederalregister.org/doc/82_FR_43751/page/1.svg)
Document Created: 2017-09-16 00:51:53
Document Modified: 2017-09-16 00:51:53
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 18, 2017. Such persons may also file a written request for a hearing on the application on or before October 18, 2017. | |
| FR Citation | 82 FR 43572 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR